Long intergenic non-protein coding RNA 1563 (LINC01563)

Long intergenic non-protein coding RNA 1563 (LINC01563) is a member of the long intergenic non-coding RNA (lincRNA) family, which are defined as autonomously transcribed RNA molecules over 200 nucleotides in length that do not overlap known protein-coding genes[1][3][5]. LINC01563 is a non-protein coding transcript and acts through RNA-based mechanisms rather than encoding a protein product[1][3]. LincRNAs have diverse molecular roles, such as regulating transcription, influencing chromatin structure, and stabilizing RNA transcripts, often with tissue-specific patterns[5][6]. They may modulate the expression of nearby or distant genes via recruitment of chromatin modifiers, scaffolding of protein complexes, and serving as molecular sponges for miRNAs[5][6]. While some lincRNAs are well-studied and implicated in disease, there is currently no evidence that LINC01563 is an established therapeutic target or directly interacts with drugs, nor is it recognized as a canonical biomarker or has defined mechanism of action as a therapeutic target[1][3][4]. In general, lincRNAs—including LINC01563—are increasingly implicated in complex regulatory networks, with possible roles in the regulation of oncogenesis and other diseases, but their individual disease associations and molecular mechanisms require more specific characterization[5][6].

Other names

HP08942LINC01563